Showing results (1351-1360 of 1,441) with videos related to

Sort By:
Pageof 145
Current Eye Research|September 18, 2024
Development of Microcystoid Macular Degeneration in the Retina of Nonhuman Primates: Time-Course and Associated PathologiesThomas C M Lavery, Carol A Rasmussen, Alexander W Katz, et al.
Cancer Causes & Control : CCC|April 27, 2000
Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancerD C Farrow, T L Vaughan, C Sweeney, et al.
Epidemiology (Cambridge, Mass.)|October 9, 2019
Early Life Exposure to Air Pollution and Autism Spectrum Disorder: Findings from a Multisite Case-Control StudyLaura A McGuinn, Gayle C Windham, Amy E Kalkbrenner, et al.
Cells|November 27, 2019
Mechanism-Specific Pharmacodynamics of a Novel Complex-I Inhibitor Quantified by Imaging Reversal of Consumptive Hypoxia with [18F]FAZA PET In VivoSeth T Gammon, Federica Pisaneschi, Madhavi L Bandi, et al.
Oncotarget|May 2, 2019
PD-L1 checkpoint blockade delivered by retroviral replicating vector confers anti-tumor efficacy in murine tumor modelsLeah A Mitchell, Kader Yagiz, Andrew Hofacre, et al.
Elife|June 27, 2014
A single vertebrate DNA virus protein disarms invertebrate immunity to RNA virus infectionDon B Gammon, Sophie Duraffour, Daniel K Rozelle, et al.
Breast Cancer Research and Treatment|May 16, 2017
Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome predictionMolly Scannell Bryan, Maria Argos, Irene L Andrulis, et al.
Gastroenterology|February 28, 2007
A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursorsGeorgina L Hold, Charles S Rabkin, Wong-Ho Chow, et al.
Plos One|July 31, 2014
Gastroesophageal reflux in relation to adenocarcinomas of the esophagus: a pooled analysis from the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON)Michael B Cook, Douglas A Corley, Liam J Murray, et al.
Journal of the American College of Cardiology|April 19, 2008
A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II studyMitchell W Krucoff, Dean J Kereiakes, John L Petersen, et al.
Pageof 145